生理疗法的有效性对异性中耳炎:一个系统性审查和元分析
Do Hyeon Kim1, Kye Hoon Park1, Yun Jin Kang1
1Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Cheonan, Korea.
The journal of international advanced otology
|August 20, 2024
概括
生物治疗显著改善症状,并降低埃索诺菲尔和IgE水平在埃索诺菲尔性中耳炎中. 然而,听力值在这些先进疗法下没有显著变化.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 乙性中耳炎 (EOM) 是一种罕见的粘性中耳病,通常与喘和慢性鼻炎有关.
- 它的病理生理学尚未完全理解,它可能对类固醇等常规治疗不耐药.
- 人们越来越认识到EMO是一种2型炎症状况,需要向治疗.
研究的目的:
- 系统地审查和元分析生物治疗EMM的疗效.
- 评估生物制剂对中耳炎相关症状,溢液粘度和炎症标志物的影响.
主要方法:
- 在主要的生物医学数据库 (PubMed,SCOPUS,Embase,Web of Science,Cochrane) 进行了全面的搜索,截至2023年9月.
- 提取的数据包括临床发现,症状评分,听力测试结果,血清乙蛋白细胞计数和免疫球蛋白E (IgE) 水平.
- 分析比较了生物治疗前后的结果,包括不同生物药物之间的比较.
主要成果:
- 与对照组相比,生物药物显著改善了与中耳炎相关的主观评分 (SMD-1.62).
- 在6-12个月的治疗后,血清中乙氨基酸细胞数量和IgE水平显著下降 (SMD-1.40).
- 听力值或气骨间隙没有显著改善. 在dupilumab与其他生物药物之间没有发现显著差异.
结论:
- 生物疗法提供了一个有前途的治疗途径,以酸性中耳炎,改善患者报告的结果和关键的炎症标志物.
- 虽然对症状和生物标志物有效,但生物药似乎无法恢复EOM患者的听力值.
- 进一步的随机对照试验是必要的,以巩固生物制剂在管理耐火性EOM中的作用,并优化治疗策略.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
255
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
255
01:19Antiasthma Drugs: Leukotriene Modifiers
260
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
260
01:17Drugs Used in Lower Respiratory Disorders: Overview
370
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
370
01:26COPD: Management Using Bronchodilators and Corticosteroids
190
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
190
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
230
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
230
01:22Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K